NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
36 hedge funds and large institutions have $6.86M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
83% less capital invested
Capital invested by funds: $39.7M → $6.86M (-$32.9M)
Holders
36
Holding in Top 10
1
Calls
$31K
Puts
$49K
Top Buyers
| 1 | +$795K | |
| 2 | +$678K | |
| 3 | +$146K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$42K |
| 5 |
VF
Virtu Financial
New York
|
+$25K |
Top Sellers
| 1 | -$5.49M | |
| 2 | -$3.03M | |
| 3 | -$1.72M | |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.31M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.01M |